Raychaudhuri, Suravi
Gem, Hakan
Chung, Kevin
McLean, Jeffrey S.
Kerns, Kristopher A.
Hullar, Meredith A. J.
Elmorr, Elissa
Appelbaum, Jacob B.
Percival, Mary-Elizabeth M.
Walter, Roland B.
Halpern, Anna B.
Minot, Samuel S.
Kim, Katie
Zevin, Alexander S.
Rashidi, Armin
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T32HL007093)
American Academy of Oral Medicine Research Advancement Committee (n/a)
National Cancer Institute (P30 CA015704, P30 CA015704)
Kuni Foundation (n/a)
Article History
Received: 29 January 2025
Accepted: 12 May 2025
First Online: 26 May 2025
Competing interests
: A.R. has received consulting fees from Seres Therapeutics (2023) and serves as a member of an Emmes Data and Safety Monitoring Board, both outside of the scope of the present study. The other authors do not have relevant competing interests.